Dr. Daniel G. Holmes, MD
Urology (Urology Physician)
- Medicare participating
At a glance
- Medical school
- University of Kansas School of Med (Kc/Wich/Sal) (1997)
- Years since graduation
- 29
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 797
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1997Medical school: University of Kansas School of Med (Kc/Wich/Sal)
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Urology Physician primary
MO license 113234 · KS license 04-28188
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- University of Kansas Hospital Kansas City, KS
- St Lukes Hospital of Kansas City Kansas City, MO
- Adventhealth Shawnee Mission Shawnee Mission, KS
- Saint Luke's South Hospital Overland PArk, KS
- Saint John Hospital Leavenworth, KS
Medical groups
- Kansas City Urology Care PA (71 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 797
- Services billed
- 6,441
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Urinalysis, manual test | 864 | 572 |
| Established patient office or other outpatient visit, 30-39 minutes | 830 | 514 |
| Ultrasound measurement of bladder capacity after voiding | 712 | 455 |
| Established patient office or other outpatient visit, 20-29 minutes | 325 | 268 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 174 | 26 |
| Psa (prostate specific antigen) measurement, total | 131 | 116 |
| Diagnostic exam of bladder and urethra using an endoscope | 125 | 105 |
| Psa (prostate specific antigen) measurement, free | 109 | 93 |
| Insertion of needle into vein for collection of blood sample | 82 | 74 |
| New patient office or other outpatient visit, 45-59 minutes | 65 | 65 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Tamsulosin Hcl Other prescribers in Kansas City, MO | 905 |
| Finasteride Other prescribers in Kansas City, MO | 834 |
| Gemtesa (vibegron) Other prescribers in Kansas City, MO | 101 |
| Alfuzosin Hcl Er (alfuzosin hcl) Other prescribers in Kansas City, MO | 90 |
| Myrbetriq (mirabegron) Other prescribers in Kansas City, MO | 88 |
| Nitrofurantoin Mono-Macro (nitrofurantoin monohyd/m-cryst) Other prescribers in Kansas City, MO | 82 |
| Solifenacin Succinate Other prescribers in Kansas City, MO | 42 |
| Ciprofloxacin Hcl Other prescribers in Kansas City, MO | 37 |
| Doxycycline Hyclate Other prescribers in Kansas City, MO | 34 |
| Dutasteride Other prescribers in Kansas City, MO | 25 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 15 companies reported 20 payments worth $635 in total to this clinician.
| Novartis Pharmaceuticals Corporation | $134 |
|---|---|
| Boston Scientific Corporation | $121 |
| Urogen Pharma, Inc. | $72.39 |
| Myriad Genetic Laboratories, Inc. | $44.56 |
| Azurity Pharmaceuticals, Inc. | $38.58 |
| AstraZeneca Pharmaceuticals LP | $35.06 |
| Axogen | $31.12 |
| Immunitybio, Inc. | $29.92 |
| Food and Beverage | $600 |
|---|---|
| Education | $35.06 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP Nov 13, 2025 | Education IMFINZI · Oncology · in-kind Company’s descriptionJournal Article | $35.06 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.